(Q33809503)

29 July 2017

1 reference

title

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications (English)

1 reference

29 July 2017

1 reference

Soriano V

1 reference

29 July 2017

Garcìa-Samaniego J

1 reference

29 July 2017

Rodrìguez-Rosado R

1 reference

29 July 2017

Gonzàlez J

1 reference

29 July 2017

Pedreira J

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31 Suppl 1

1 reference

29 July 2017

page(s)

119-123

1 reference

Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Impact of immunosuppression caused by HIV infection on the replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Hepatotoxicity after introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Management of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Time to hit HIV, early and hard.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980387-0

7 January 2021

10.1016/S0168-8278(99)80387-0

Identifiers

DOI

1 reference

29 July 2017

1 reference